Skip to main content

Table 1 Group demographics for patients under and over 50 years old

From: Metal-on-metal hip resurfacing in patients younger than 50 years: a retrospective analysis

 

Group 1, <50 (N = 1285)

Group 2, ≥50 (N = 1984)

p value

Sex (no. of hips)

 Male

951 (74%)

1426 (72%)

0.1802

 Female

334 (26%)

558 (28%)

Deceased#

10 (0.8%)

29 (1.5%)

0.0784

F/U mean years

3.4 ± 2.98

2.8 ± 2.59

<0.0001*

Lost to F/U

17 (1.3%)

23 (1.2%)

0.6745

Case date range

1/2001–8/2013

Age (years)

44 ± 6.02

57 ± 4.23

<0.0001*

BMI

28 ± 4.92

28 ± 4.56

0.0750

T-score

0.26 ± 1.36

−0.14 ± 1.18

<0.0001*

Uncemented fixation (no. of hips)

776 (60%)

1380 (70%)

<0.0001*

10-year survivorship (no. of hips)

1234 (96%)

1924 (97%)

0.1443

Diagnosis (no. of hips)

 Dysplasia

149 (12%)

214 (11%)

0.4715

 Osteoarthritis (OA)

866 (67%)

1589 (80%)

<0.0001*

 Osteonecrosis (ON)

107 (8.3%)

63 (3.2%)

<0.0001*

 Rheumatoid arthritis (RA)

9 (0.7%)

2 (0.1%)

0.0039*

 Post-trauma

40 (3.1%)

20 (1.0%)

<0.0001*

 Legg-Calve-Perthes disease (LCP)

32 (2.5%)

7 (0.4%)

<0.0001*

 Slipped capital femoral epiphysis (SCFE)

12 (0.9%)

9 (0.5%)

0.0930

 Other

22 (1.7%)

21 (1.1%)

0.1096

Implants (no. of hips)

 Corin Cormet 2000

187 (14%)

185 (9.3%)

<0.0001*

 Biomet ReCap™-Magnum™ hybrid

330 (26%)

409 (21%)

0.0007*

 Biomet ReCap™-Magnum™ uncemented

768 (60%)

1390 (70%)

<0.0001*

ASA score

1.6 ± 0.57

1.7 ± 0.58

<0.0001*

Femoral component <48 mm (no. of hips)

199/973 (20%)

334/1641 (20%)

0.9522

Femoral component size

50.0 ± 3.92

50.2 ± 3.53

0.1793

  1. Statistically significant p values are italicized and denoted by an asterisk (*)
  2. #indicates deaths unrelated to the patients' hip arthroplasties